Literature DB >> 30907318

In Silico Evaluation of Acetylation Mimics in the 27 Lysine Residues of Human Tau Protein.

Yong-Chan Kim1,2, Byung-Hoon Jeong1,2.   

Abstract

BACKGROUND: Various neurodegenerative diseases, including Alzheimer's disease (AD), are related to abnormal hyperphosphorylated microtubule-associated protein tau accumulation in brain lesions. Recent studies have focused on toxicity caused by another post-translational modification (PTM), acetylation of the lysine (K) residues of tau protein. Because there are numerous acetylation sites, several studies have introduced mimics of tau acetylation using amino acid substitutions from lysine to glutamine (Q). However, human tau protein contains over 20 acetylation sites; thus, investigation of the effects of an acetylated tau is difficult.
OBJECTIVE: Here, the authors in silico evaluated acetylation effects using SIFT, PolyPhen-2 and PROVEAN which can estimate the effects of amino acid substitutions based on the sequence homology or protein structure in tau isoforms. In addition, they also investigated 27 acetylation effects on the amyloid formation of tau proteins using Waltz.
RESULTS: 15 acetylation mimics were estimated to be the most detrimental, which indicates that there may be novel pathogenic acetylation sites in the human tau protein. Interestingly, the deleterious effect of acetylation mimics was different according to the type of isoforms. Furthermore, all acetylation mimics were predicted to be a region of amyloid formation at the codons 274-279 of human tau protein. Notably, acetylation mimic of codon 311 (K311Q) induced the formation of an additional amyloid region located on codons 306-311 of the human tau protein.
CONCLUSION: To the best of our knowledge, this is the first simultaneous in-silico evaluation of the acetylation state of 27 human tau protein residues. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Alzheimer's disease; In-silico analysis; acetylation; mimic; neurodegenerative diseases; tau.

Year:  2019        PMID: 30907318     DOI: 10.2174/1567205016666190321161032

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  7 in total

1.  Identification of Prion Disease-Related Somatic Mutations in the Prion Protein Gene (PRNP) in Cancer Patients.

Authors:  Yong-Chan Kim; Sae-Young Won; Byung-Hoon Jeong
Journal:  Cells       Date:  2020-06-17       Impact factor: 6.600

2.  Scrapie susceptibility-associated indel polymorphism of shadow of prion protein gene (SPRN) in Korean native black goats.

Authors:  Yong-Chan Kim; Seon-Kwan Kim; Byung-Hoon Jeong
Journal:  Sci Rep       Date:  2019-10-24       Impact factor: 4.379

3.  Polymorphisms of shadow of prion protein gene (SPRN) in Korean native cattle (Hanwoo) and Holstein cattle.

Authors:  Yong-Chan Kim; Seon-Kwan Kim; Sae-Young Won; Byung-Hoon Jeong
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

4.  Unraveling the Influence of K280 Acetylation on the Conformational Features of Tau Core Fragment: A Molecular Dynamics Simulation Study.

Authors:  Yu Zou; Lulu Guan
Journal:  Front Mol Biosci       Date:  2021-12-13

5.  Novel Polymorphisms and Genetic Characteristics of the Prion Protein Gene (PRNP) in Dogs-A Resistant Animal of Prion Disease.

Authors:  Dong-Ju Kim; Yong-Chan Kim; An-Dang Kim; Byung-Hoon Jeong
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

6.  Absence of Strong Genetic Linkage Disequilibrium between Single Nucleotide Polymorphisms (SNPs) in the Prion Protein Gene (PRNP) and the Prion-Like Protein Gene (PRND) in the Horse, a Prion-Resistant Species.

Authors:  Sae-Young Won; Yong-Chan Kim; Kyoungtag Do; Byung-Hoon Jeong
Journal:  Genes (Basel)       Date:  2020-05-07       Impact factor: 4.096

7.  No Association between Single Nucleotide Polymorphisms (SNPs) of the Interferon-Induced Transmembrane Protein 3 (IFITM3) Gene and the Susceptibility of Alzheimer's Disease (AD).

Authors:  Sae-Young Won; Yong-Chan Kim; Byung-Hoon Jeong
Journal:  Medicina (Kaunas)       Date:  2021-12-30       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.